June 18 (Reuters) - Mind Medicine (MindMed) Inc MMED.NLB :
* MINDMED TO EVALUATE AYAHUASCA'S ACTIVE INGREDIENT DMT IN PHASE 1 CLINICAL TRIAL COLLABORATION
June 18 (Reuters) - Mind Medicine (MindMed) Inc MMED.NLB :
* MINDMED TO EVALUATE AYAHUASCA'S ACTIVE INGREDIENT DMT IN PHASE 1 CLINICAL TRIAL COLLABORATION